Out-of-network providers are inflating the price of COVID-19 diagnostic and antibody tests, according to a report from America's Health Insurance Plans.
AHIP conducted a survey of its member plans in the commercial market and received 22 responses, which represented 67 percent of commercial enrollment of member plans. Responses were weighted based on plans' enrollment.
Under the Coronavirus Aid, Relief and Economic Security Act, health insurers have to pay the listed cash price for COVID-19 tests to out-of-network providers. AHIP said this has resulted in price gouging, as payers and providers can't negotiate test prices.
COVID-19 tests usually cost $130. AHIP says out-of-network providers charge more than $185 for 39 percent of diagnostic tests and 25 percent of antibody tests, with 1 in 10 out-of-network providers charging more than $390.
"The Administration should take steps to prevent price gouging for COVID-19 testing, including enforcing the requirement that test providers publicly post their cash price in an easy-to-find online location," AHIP said.
More articles on payers:
Aetna fined for denying ER claims in California
BCBS of Tennessee threatens to sue data firm over report finding provider overcharges
24 payer exec moves in August